MMManzoor Ur Rahman Mir

Manzoor Ur Rahman Mir

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Manzoor Ur Rahman Mir has a total of 90 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Investigations on cytokines and proteins in lactating cows with and without naturally occurring mastitis

    by Tabasum Shaheen, Sheikh Bilal Ahmad, Muneeb U. Rehman, Showkeen Muzamil, Rahil Razak Bhat, Ishraq Hussain, Nazirah Bashir, Manzoor Ur Rahman Mir, Bilal Ahamad Paray, Mahmoud A.O. Dawood


  • Zingerone prevents lead‐induced toxicity in liver and kidney tissues by regulating the oxidative damage in Wistar rats

    by Insha Amin, Ishraq Hussain, Muneeb U. Rehman, Bilal Ahmad Mir, Showkat Ahmad Ganaie, Sheikh Bilal Ahmad, Manzoor Ur Rahman Mir, Syed Shanaz, Showkeen Muzamil, Azher Arafah, et al.

    Among the heavy metal poisonings, lead is considered as a major toxic metal causing hematological, neurological, immunological, hepatic, and renal dysfunctions. Lead causes inhibition of ALAD leading to the ALA accumulation inside the cells. Lead also leads to disruption of the anti‐oxidative enzyme system, organ function, and lipid membranes of the cell causing oxidative stress. Zingerone, a phenolic alkanone, is an active edible ingredient present in the ginger that possess varied pharmacological properties. The aim of our study was to evaluate the protective effect of zingerone in lead‐induced toxicity in wistar rats. ALAD concentration was improved in kidney and liver tissues treated with zingerone. Protective effect of zingerone was observed in terms of significant improvement in kidney and liver histology, anti‐oxidant enzyme activity (CAT, SOD, GPx, and GR), organ function parameters, lipid profile, and decreased level of LPO. Therefore, zingerone pretreatment can be a promising agent for alleviation of lead‐induced oxidative damage in cells. Practical applications Published reports have revealed that consumption of certain bioactive nutrients for example, flavonoids, mineral elements, and vitamins can offer defense from the environmental lead contamination. Zingerone is a strong anti‐oxidant, with very less side effects and has exceptional property of scavenging free radicals, hence reducing the oxidative stresses. This fundamental property of zingerone can alone help in countering the heavy metal toxicity. Different groups have published reported numerous properties of zingerone but as per our understanding till date no study about alleviation of lead toxicity by zingerone in animal model has been undertaken. Hence, we conducted this research to explore the preventive effect of zingerone in lead induced kidney and liver toxicity. The outcome of our study shows potent anti‐oxidant effect and ALAD modulatory property of zingerone which makes it suitable edible candidate for use in countering lead toxicity.


  • Chemical Composition and Biological Uses of Artemisia absinthium (Wormwood)

    by Rahil Razzak Bhat, Muneeb U. Rehman, Ambreen Shabir, Manzoor U. Rahman Mir, Anas Ahmad, Rehan Khan, Mubashir Husaain Masoodi, Hassan Madkhali, Majid Ahmad Ganaie


  • Abiotic Stress and Plant Senescence

    by Saiema Rasool, Bilal Ahmad Mir, Muneeb U Rehman, Insha Amin, Manzoor Ur Rahman Mir, Sheikh Bilal Ahmad


  • Open Access

    Zingerone (4-(4-hydroxy-3-methylphenyl) butan-2-one) protects against alloxan-induced diabetes via alleviation of oxidative stress and inflammation: Probable role of NF-kB activation

    by Bilal Ahmad, Muneeb U. Rehman, Insha Amin, Manzoor Ur Rahman Mir, Sheikh Bilal Ahmad, Adil Farooq, Showkeen Muzamil, Ishraq Hussain, Mubashir Masoodi, Bilques Fatima

    Diabetes is considered as the most common metabolic disease affecting millions of people all around the world. Use of natural herbal medicines can be effective in treating diabetes. Zingerone (4-(4-hydroxy-3-methylphenyl) butan-2-one) a polyphenolic alkanone extracted from ginger has a broad spectrum of pharmacological properties and thus can be used as a promising candidate against various ailments. In the current study we aimed at demonstrating the protective effect of zingerone against diabetes mellitus and elucidating its possible mechanism. Five groups of animals (I-V) were made with ten animals each. Group I (control) was given normal saline orally. Group II (diabetic positive control) was given alloxan at the dose rate of 100 mg/kg bwt once. Group III and IV was given alloxan once at the dose rate of 100 mg/kg bwt. and received oral treatment of zingerone at a dose rate of 50 and 100 mg/kg bwt respectively daily for 21 days. Group V was given alloxan at the dose of 100 mg/kg bwt. and was treated with standard drug glibenclamide at the dose rate of 4.5 mg/kg bwt. daily for 21 days. According to our findings we confirmed that zingerone restrained the alloxan induced oxidative stress by increasing the activity of reduced glutathione (GSH), superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPX) and reducing the peroxidative damage. We also confirmed that zingerone suppressed the level of redox sensitive transcription factor NFκB and downregulated other downstream inflammatory cytokines like interleukins (IL1-β IL-2, IL-6) and tumor necrosis factor alpha (TNF-α). Moreover, the experimental findings suggested that zingerone improved the insulin levels. Taken together our results indicated that zingerone effectively ameliorated the diabetes induced complications which provide a strong theoretical basis for zingerone to be used clinically for treatment of diabetes.


  • Open Access

    Diagnostic utility of glycosyltransferase mRNA expression in gastric cancer

    by Showkat Ahmad Bhat, Manzoor Ur Rahman Mir, Sabhiya Majid, Tehseen Hassan, Muneeb U. Rehman, Sonallah Kuchy

    Objective/background: Posttranslational modification of proteins, including glycosylation, is known to differ between normal and tumor cells. Altered glycosyltransferase levels have been observed in tumor tissues and their role in tumor metastasis and invasion has been implicated. In this study the role of altered glycosyltransferase messenger RNA (mRNA) levels in serum of gastric cancer patients as early markers of gastric cancer was evaluated. Methods: In this case control study the expression profile of ppGalNAc-T6, GlcNAcT-V, ST3Gal I, ST3 Gal IV, and ST6GalNAc-I in normal healthy control and gastric cancer patients was compared. Serum was isolated from blood samples of gastric cancer patients (n = 200) and controls (n = 200). Following RNA extraction, reverse transcription was carried out and transcript levels of glycosyltransferases were determined using real-time quantitative polymerase chain reaction and normalized against glyceraldehyde-3-phosphate dehydrogenase (GAPDH) expression. The amount of target gene, normalized to an endogenous reference gene relative to calibrator was calculated by using ΔΔCT method. Transcript levels in the serum samples of gastric cancer patients were compared with those of controls; also the same was correlated within sex and different stages of disease. Results: The mRNA expression of ppGalNAc-T6 and ST6GalNAc-I was significantly higher in serum samples of gastric cancer patients on comparison with controls (p = .008), however, there was no significant difference in mRNA expression of GlcNAcT-V, ST3Gal I, and ST3 Gal IV in serum samples of gastric cancer patients and controls (p = .097). In addition, no significant association of mRNA expression of these glycosyltransferases was found within sex and stages in this study. Conclusion: This study revealed the potential of ppGalNAc-T6 and ST6GalNAc-I mRNA transcript levels in serum as markers of gastric cancer. Further studies on the wider range of glycosyltransferases in various cancers are needed to establish signature mRNA batteries as minimally invasive markers of gastric cancer.


  • Naringenin (4,5,7‐trihydroxyflavanone) suppresses the development of precancerous lesions via controlling hyperproliferation and inflammation in the colon of Wistar rats

    by Muneeb U. Rehman, Manzoor Ur Rahman Mir, Adil Farooq, Shahzada Mudasir Rashid, Bilal Ahmad, Sheikh Bilal Ahmad, Rayeesa Ali, Ishraq Hussain, Mubashir Masoodi, Showkeen Muzamil, et al.

    Colon cancer is a world‐wide health problem and one of the most dangerous type of cancer, affecting both men and women. Naringenin (4, 5, 7‐trihydroxyflavanone) is one of the major flavone glycoside present in citrus fruits. Naringenin has long been used in Chinese's traditional medicine because of its exceptional pharmacological properties and non‐toxic nature. In the present study, we investigated the chemopreventive potential of Naringenin against 1,2‐dimethyhydrazine (DMH)‐induced precancerous lesions, that is, aberrant crypt foci (ACF) and mucin depleted foci (MDF), and its role in regulating the oxidative stress, inflammation and hyperproliferation, in the colon of Wistar rats. Animals were divided into five groups. In groups 3‐5, Naringenin was administered at the dose of 50 mg/kg b. wt. orally while in groups 2‐4, DMH was administered subcutaneously in the groin at the dose of 20 mg/kg b. wt. once a week for first 5 weeks and animals were euthanized after 10 weeks. Administration of Naringenin ameliorated the development of DMH‐induced lipid peroxidation, ROS formation, precancerous lesions (ACF and MDF) and it also reduced the infiltration of mast cells, suppressed the immunostaining of NF‐κB‐p65, COX‐2, i‐NOS PCNA and Ki 67 Naringenin treatment significantly attenuated the level of TNF‐α and it also prevented the depletion of the mucous layer. Our findings suggest that Naringenin has strong chemopreventive potential against DMH‐induced colon carcinogenesis but further studies are warranted to elucidate the precise mechanism of action of Naringenin.


  • Chemoprotective potential of zingerone (vanillyl acetone) in cyclophosphamide-induced hepatic toxicity

    by Manzoor-Ur- Rahman Mir, Bilal Ahmad Mir, Insha Amin, Muneeb U Rehman, Rahil Razak, Aarif Ali, Omer Khalil Baba, Bilques Fatima, Rayeesa Ali, Sheikh Bilal, et al.

    Introduction: Cancer is one of the lethal diseases in the global world. Proliferation of cancer cells is commonly inhibited by chemotherapeutics. Cyclophosphamide (CP) is an alkylating chemotherapeutic agent often used for treatment of various types of cancers, but it is full of side effects which in turn lead to organ toxicity. Zingerone, a polyphenolic alkanone found in ginger, has strong antioxidant potential and causes extensive scavenging of free radicals and offers defense against oxidative stress. Twenty-four adult male Wistar rats were divided into four groups, six rats in each group. Materials and Methods: Group I (control), Group II (CP, 2 mg/kg bwt), Group III (cotreatment with zingerone at the dose of 50 mg/kg bwt and CP at the dose of 2 mg/kg bwt), and Group IV (pretreatment of zingerone at the dose of 50 mg/kg bwt for 7 days and CP at the dose of 2 mg/kg bwt for next 7 days). Results: CP significantly increased the level of hepatic marker enzymes such as alanine aminotransferase, aspartate aminotransferase, and alkaline phosphatase, drastically caused alteration in lipid profile and deficiency in antioxidant defense mechanism by decreasing the activities of antioxidant enzymes such as catalase, glutathione, glutathione-S-transferase, and glutathione peroxidase. This was accompanied by subsequent increase in lipid peroxidation, nitrite production, and marked DNA damage. Conclusion: The restoration of hepatic markers, amelioration of lipid profile, and improvement of antioxidant status and DNA damage by pre- and co-treatment with zingerone clearly indicate the ameliorative potential of zingerone against CP-induced organ toxicity and oxidative stress. The protective potential of zingerone may be attributed to its strong antioxidant activity. Abbreviations used: CP: Cyclophosphamide; ALT: Alanine transaminase; AST: Aspartate transaminase; ALP: Alkaline phosphatase; CAT: Catalase; GSH: Reduced glutathione; ROS: Reactive oxygen species; SOD: Superoxide dismutase; LPO: lipid peroxidation; MDA: Malonaldehyde; GPX: Glutathione peroxidase.


  • Antifibrotic effects of D‐limonene (5(1‐methyl‐4‐[1‐methylethenyl]) cyclohexane) in CCl4 induced liver toxicity in Wistar rats

    by Sheikh Bilal Ahmad, Muneeb U. Rehman, Bilques Fatima, Bilal Ahmad, Ishraq Hussain, Sheikh Pervaiz Ahmad, Adil Farooq, Showkeen Muzamil, Rahil Razzaq, Shahzada Mudasir Rashid, et al.

    This study was designed to assess the potential antifibrotic effect of D‐Limonene—a component of volatile oils extracted from citrus plants. D‐limonene is reported to have numerous therapeutic properties. CCl4‐intduced model of liver fibrosis in Wistar rats is most widely used model to study chemopreventive studies. CCl4‐intoxication significantly increased serum aminotransferases and total cholesterol these effects were prevented by cotreatment with D‐Limonene. Also, CCl4‐intoxication caused depletion of glutathione and other antioxidant enzymes while D‐Limonene preserved them within normal values. Hydroxyproline and malondialdehyde content was increased markedly by CCl4 treatment while D‐Limonene prevented these alterations. Levels of TNF‐α, TGF‐β, and α‐SMA were also assessed; CCl4 increased the expression of α‐SMA, NF‐κB and other downstream inflammatory cascade while D‐Limonene co‐treatment inhibited them. Collectively these findings indicate that D‐Limonene possesses potent antifibrotic effect which may be attributed to its antioxidant and anti‐inflammatory properties.


  • Open Access

    Effect of naringenin (A naturally occurring flavanone) against pilocarpine-induced status epilepticus and oxidative stress in mice

    by Nahida Tabassum, Sheeba Shakeel, Muneeb U Rehman, Umar Amin, Manzoor Ur Rahman Mir

    Background: Epilepsy is a disorder of the central nervous system characterized by recurrent seizures. It is a very common disease in which approximately 30% of patients do not respond favourably to treatment with anticonvulsants. Oxidative stress is associated with neuronal damage arising from epileptic seizures. The present study investigated the effects of naringenin in pilocarpine-induced epilepsy in mice. Naringenin, one of the most frequently occurring flavanone in citrus fruits, was evaluated for its shielding effect against the pilocarpine induced behavioural, oxidative and histopathological alterations in rodent model of epilepsy. Methodology: Epilepsy was induced by giving pilocarpine (300mg/kg) and sodium valproate (300mg/kg) was given as standard anti-epileptic drug Pilocarpine was administered (300 mg /kg body weight) intraperitoneally to the mice on 15th day while naringenin was administered orally (20 and 40 mg/kg body weight) for 15 days prior to administration of pilocarpine. Results: The intraperitoneal administration of pilocarpine enhanced lipid peroxidation, caused reduction in antioxidant enzymes, viz., catalase, superoxide dismutase and glutathione reductase. Treatment of mice orally with naringenin (20 mg/kg body weight and 40 mg/kg body weight) resulted in a significant decrease in lipid peroxidation. There was significant recovery of glutathione content and all the antioxidant enzymes studied. Also in case of behavioural parameters studied, naringenin showed decrease in seizure severity. All these changes were supported by histological observations, which revealed excellent improvement in neuronal damage. Conclusion: The higher dose of naringenin was more potent in our study and was comparable to the standard drug (sodium valproate) in effectiveness. Abbreviations used:6-OHDA: 6-hydroxydopamine, AED: Anti epileptic drugs, AIDS: Acquired immune deficiency syndrome, ANOVA: Analysis of variance, ATP: Adenosine triphosphate, CA: Cornu ammonis, CAT: Catalase, DG: Dentate gyrus, EDTA: Ethylenediamine tetra acetic acid, GR: Glutathione reductase, GSH: Glutathione reduced, HCl: Hydrochloric acid, IL-1β: Interleukin 1 beta, LPO: Lipid peroxidation, MDA: Malondialdehyde, NADPH: Nicotinamide adenine dinucleotide phosphate, PMS: post mitochondrial supernatant, SE: Status epilepticus, SEM: Standard error of the mean, SOD Superoxide dismutase, TBA: Thiobarbituric acid, TBARS: Thiobarbituric acid reactive substance, TLE: Temporal lobe epilepsy, TNF-α: Tumor necrosis factor alpha